ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines-Reference-Cited by-同舟云学术

ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines

Published:2022-06-17 Issue:6 Volume:16 Page:9240-9253
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Liu Xu¹,Liu Yu¹,Li Xiang¹,Huang Jiaxin¹,Guo Xuemeng¹,Zhang Junlei¹,Luo Zhenyu¹,Shi Yingying¹,Jiang Mengshi¹,Qin Bing¹,Du Yongzhong¹^ORCID,Luo Lihua¹,You Jian¹^ORCID

Affiliation:

1. College of Pharmaceutical Sciences, Zhejiang University, 886 Yuhangtang Road, Hangzhou, Zhejiang 310058, People’s Republic of China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.2c01669

Reference45 articles.

1. Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy

2. Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions

3. Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

4. Tumor Cell Vaccines

5. Personalized vaccines for cancer immunotherapy

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fucoidan based Ce6-chloroquine self-assembled hydrogel as in situ vaccines to enhance tumor immunotherapy by autophagy inhibition and macrophage polarization;Carbohydrate Polymers;2024-12

2. Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer;Journal of Colloid and Interface Science;2024-10

3. Photodynamic therapy of cancer using graphene nanomaterials;Expert Opinion on Drug Delivery;2024-09-02

4. Design of multifunctional theranostic nanoplatforms with glutathione-triggered H2S generation and H2S-activitated multi-modal therapy;Chemical Engineering Journal;2024-09

5. In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases;Acta Pharmaceutica Sinica B;2024-09